nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0771	0.147	CbGbCtD
Risperidone—CYP3A7—Vincristine—muscle cancer	0.0771	0.147	CbGbCtD
Risperidone—ABCB1—Dactinomycin—muscle cancer	0.0611	0.117	CbGbCtD
Risperidone—CYP3A5—Vincristine—muscle cancer	0.0578	0.11	CbGbCtD
Risperidone—CYP3A5—Etoposide—muscle cancer	0.053	0.101	CbGbCtD
Risperidone—ABCB1—Vincristine—muscle cancer	0.0376	0.0718	CbGbCtD
Risperidone—ABCB1—Etoposide—muscle cancer	0.0345	0.0658	CbGbCtD
Risperidone—ABCB1—Doxorubicin—muscle cancer	0.0235	0.0449	CbGbCtD
Risperidone—ABCB1—Methotrexate—muscle cancer	0.0228	0.0435	CbGbCtD
Risperidone—CYP3A4—Vincristine—muscle cancer	0.0226	0.043	CbGbCtD
Risperidone—CYP2D6—Doxorubicin—muscle cancer	0.0222	0.0423	CbGbCtD
Risperidone—CYP3A4—Etoposide—muscle cancer	0.0207	0.0394	CbGbCtD
Risperidone—CYP3A4—Doxorubicin—muscle cancer	0.0141	0.0269	CbGbCtD
Risperidone—HTR2A—hindlimb—muscle cancer	0.00337	0.0452	CbGeAlD
Risperidone—HTR2A—appendage—muscle cancer	0.00289	0.0387	CbGeAlD
Risperidone—H1F0—embryo—muscle cancer	0.0025	0.0334	CbGeAlD
Risperidone—DRD4—testis—muscle cancer	0.0024	0.0321	CbGeAlD
Risperidone—ADRA1B—renal system—muscle cancer	0.002	0.0268	CbGeAlD
Risperidone—H1F0—smooth muscle tissue—muscle cancer	0.00196	0.0263	CbGeAlD
Risperidone—H1F0—renal system—muscle cancer	0.00189	0.0253	CbGeAlD
Risperidone—DRD3—head—muscle cancer	0.00174	0.0233	CbGeAlD
Risperidone—H1F0—cardiac atrium—muscle cancer	0.00169	0.0227	CbGeAlD
Risperidone—H1F0—tendon—muscle cancer	0.00148	0.0197	CbGeAlD
Risperidone—H1F0—bone marrow—muscle cancer	0.00143	0.0191	CbGeAlD
Risperidone—HTR2B—smooth muscle tissue—muscle cancer	0.00141	0.0189	CbGeAlD
Risperidone—H1F0—vagina—muscle cancer	0.00137	0.0183	CbGeAlD
Risperidone—ADRA1B—head—muscle cancer	0.00134	0.0179	CbGeAlD
Risperidone—H1F0—head—muscle cancer	0.00126	0.0169	CbGeAlD
Risperidone—DRD1—head—muscle cancer	0.00125	0.0167	CbGeAlD
Risperidone—H1F0—testis—muscle cancer	0.00122	0.0164	CbGeAlD
Risperidone—HTR1A—renal system—muscle cancer	0.00122	0.0163	CbGeAlD
Risperidone—HTR7—smooth muscle tissue—muscle cancer	0.00121	0.0162	CbGeAlD
Risperidone—HTR7—renal system—muscle cancer	0.00117	0.0156	CbGeAlD
Risperidone—ADRA1A—renal system—muscle cancer	0.00112	0.0151	CbGeAlD
Risperidone—KCNH2—renal system—muscle cancer	0.00109	0.0145	CbGeAlD
Risperidone—ADRA2C—renal system—muscle cancer	0.00107	0.0143	CbGeAlD
Risperidone—HTR2B—tendon—muscle cancer	0.00106	0.0142	CbGeAlD
Risperidone—HTR1B—head—muscle cancer	0.00101	0.0135	CbGeAlD
Risperidone—HTR2B—vagina—muscle cancer	0.000986	0.0132	CbGeAlD
Risperidone—HTR1D—head—muscle cancer	0.00098	0.0131	CbGeAlD
Risperidone—KCNH2—cardiac atrium—muscle cancer	0.000973	0.013	CbGeAlD
Risperidone—HTR2C—head—muscle cancer	0.00097	0.013	CbGeAlD
Risperidone—HTR2A—embryo—muscle cancer	0.000961	0.0129	CbGeAlD
Risperidone—ADRA2C—cardiac atrium—muscle cancer	0.00096	0.0129	CbGeAlD
Risperidone—HTR2B—head—muscle cancer	0.000911	0.0122	CbGeAlD
Risperidone—HTR7—tendon—muscle cancer	0.00091	0.0122	CbGeAlD
Risperidone—HRH1—smooth muscle tissue—muscle cancer	0.000905	0.0121	CbGeAlD
Risperidone—CYP3A5—renal system—muscle cancer	0.000897	0.012	CbGeAlD
Risperidone—ADRA2C—tendon—muscle cancer	0.000837	0.0112	CbGeAlD
Risperidone—KCNH2—bone marrow—muscle cancer	0.000821	0.011	CbGeAlD
Risperidone—HTR1A—head—muscle cancer	0.000816	0.0109	CbGeAlD
Risperidone—KCNH2—vagina—muscle cancer	0.000787	0.0105	CbGeAlD
Risperidone—HTR7—head—muscle cancer	0.00078	0.0104	CbGeAlD
Risperidone—ADRA2C—vagina—muscle cancer	0.000776	0.0104	CbGeAlD
Risperidone—ADRA2A—cardiac atrium—muscle cancer	0.000766	0.0103	CbGeAlD
Risperidone—HTR2A—smooth muscle tissue—muscle cancer	0.000756	0.0101	CbGeAlD
Risperidone—HTR7—testis—muscle cancer	0.000754	0.0101	CbGeAlD
Risperidone—ADRA1A—head—muscle cancer	0.000753	0.0101	CbGeAlD
Risperidone—DRD2—head—muscle cancer	0.000738	0.00988	CbGeAlD
Risperidone—HTR2A—renal system—muscle cancer	0.000727	0.00974	CbGeAlD
Risperidone—KCNH2—head—muscle cancer	0.000727	0.00973	CbGeAlD
Risperidone—ADRA2C—head—muscle cancer	0.000717	0.0096	CbGeAlD
Risperidone—DRD2—testis—muscle cancer	0.000713	0.00954	CbGeAlD
Risperidone—KCNH2—testis—muscle cancer	0.000702	0.0094	CbGeAlD
Risperidone—ADRA2C—testis—muscle cancer	0.000693	0.00927	CbGeAlD
Risperidone—HRH1—tendon—muscle cancer	0.00068	0.0091	CbGeAlD
Risperidone—CYP3A4—renal system—muscle cancer	0.000673	0.00901	CbGeAlD
Risperidone—ADRA2A—tendon—muscle cancer	0.000668	0.00894	CbGeAlD
Risperidone—CYP2D6—renal system—muscle cancer	0.000663	0.00887	CbGeAlD
Risperidone—CYP3A5—vagina—muscle cancer	0.00065	0.0087	CbGeAlD
Risperidone—HRH1—vagina—muscle cancer	0.000631	0.00844	CbGeAlD
Risperidone—ABCB1—embryo—muscle cancer	0.00063	0.00843	CbGeAlD
Risperidone—ADRA2A—vagina—muscle cancer	0.00062	0.00829	CbGeAlD
Risperidone—HRH1—head—muscle cancer	0.000583	0.0078	CbGeAlD
Risperidone—ADRA2A—head—muscle cancer	0.000572	0.00766	CbGeAlD
Risperidone—HTR2A—tendon—muscle cancer	0.000568	0.0076	CbGeAlD
Risperidone—HRH1—testis—muscle cancer	0.000563	0.00753	CbGeAlD
Risperidone—ADRA2A—testis—muscle cancer	0.000553	0.0074	CbGeAlD
Risperidone—HTR2A—vagina—muscle cancer	0.000527	0.00705	CbGeAlD
Risperidone—HTR2A—head—muscle cancer	0.000487	0.00651	CbGeAlD
Risperidone—ABCB1—renal system—muscle cancer	0.000477	0.00638	CbGeAlD
Risperidone—HTR2A—testis—muscle cancer	0.00047	0.00629	CbGeAlD
Risperidone—CYP2D6—head—muscle cancer	0.000443	0.00593	CbGeAlD
Risperidone—CYP2D6—testis—muscle cancer	0.000428	0.00573	CbGeAlD
Risperidone—Photosensitivity reaction—Methotrexate—muscle cancer	0.000364	0.000906	CcSEcCtD
Risperidone—Hypokalaemia—Doxorubicin—muscle cancer	0.000363	0.000905	CcSEcCtD
Risperidone—Breast disorder—Doxorubicin—muscle cancer	0.000361	0.000899	CcSEcCtD
Risperidone—Anorexia—Etoposide—muscle cancer	0.00036	0.000899	CcSEcCtD
Risperidone—ABCB1—bone marrow—muscle cancer	0.00036	0.00482	CbGeAlD
Risperidone—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000359	0.000896	CcSEcCtD
Risperidone—Diarrhoea—Dactinomycin—muscle cancer	0.000358	0.000891	CcSEcCtD
Risperidone—Pneumonia—Methotrexate—muscle cancer	0.000357	0.000891	CcSEcCtD
Risperidone—Nasopharyngitis—Doxorubicin—muscle cancer	0.000357	0.00089	CcSEcCtD
Risperidone—Infestation—Methotrexate—muscle cancer	0.000355	0.000885	CcSEcCtD
Risperidone—Infestation NOS—Methotrexate—muscle cancer	0.000355	0.000885	CcSEcCtD
Risperidone—Drowsiness—Methotrexate—muscle cancer	0.000355	0.000885	CcSEcCtD
Risperidone—Depression—Methotrexate—muscle cancer	0.000354	0.000883	CcSEcCtD
Risperidone—Hypotension—Etoposide—muscle cancer	0.000353	0.000881	CcSEcCtD
Risperidone—Gastritis—Doxorubicin—muscle cancer	0.000353	0.00088	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000352	0.000878	CcSEcCtD
Risperidone—Muscular weakness—Doxorubicin—muscle cancer	0.000352	0.000877	CcSEcCtD
Risperidone—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000352	0.000877	CcSEcCtD
Risperidone—Renal failure—Methotrexate—muscle cancer	0.000349	0.00087	CcSEcCtD
Risperidone—Abdominal distension—Doxorubicin—muscle cancer	0.000347	0.000866	CcSEcCtD
Risperidone—Stomatitis—Methotrexate—muscle cancer	0.000346	0.000863	CcSEcCtD
Risperidone—Conjunctivitis—Methotrexate—muscle cancer	0.000345	0.000861	CcSEcCtD
Risperidone—ABCB1—vagina—muscle cancer	0.000345	0.00462	CbGeAlD
Risperidone—Influenza—Doxorubicin—muscle cancer	0.000345	0.00086	CcSEcCtD
Risperidone—Dysphagia—Doxorubicin—muscle cancer	0.000345	0.00086	CcSEcCtD
Risperidone—Asthma—Doxorubicin—muscle cancer	0.000345	0.00086	CcSEcCtD
Risperidone—Hypersensitivity—Vincristine—muscle cancer	0.000344	0.000857	CcSEcCtD
Risperidone—Sweating—Methotrexate—muscle cancer	0.000341	0.000849	CcSEcCtD
Risperidone—Paraesthesia—Etoposide—muscle cancer	0.00034	0.000847	CcSEcCtD
Risperidone—Haematuria—Methotrexate—muscle cancer	0.000339	0.000844	CcSEcCtD
Risperidone—Pancreatitis—Doxorubicin—muscle cancer	0.000338	0.000843	CcSEcCtD
Risperidone—Dyspnoea—Etoposide—muscle cancer	0.000337	0.000841	CcSEcCtD
Risperidone—Somnolence—Etoposide—muscle cancer	0.000336	0.000838	CcSEcCtD
Risperidone—Angina pectoris—Doxorubicin—muscle cancer	0.000336	0.000838	CcSEcCtD
Risperidone—Hepatobiliary disease—Methotrexate—muscle cancer	0.000336	0.000837	CcSEcCtD
Risperidone—Epistaxis—Methotrexate—muscle cancer	0.000335	0.000835	CcSEcCtD
Risperidone—Asthenia—Vincristine—muscle cancer	0.000335	0.000835	CcSEcCtD
Risperidone—Vomiting—Dactinomycin—muscle cancer	0.000332	0.000828	CcSEcCtD
Risperidone—Bronchitis—Doxorubicin—muscle cancer	0.000332	0.000827	CcSEcCtD
Risperidone—Agranulocytosis—Methotrexate—muscle cancer	0.000331	0.000826	CcSEcCtD
Risperidone—Rash—Dactinomycin—muscle cancer	0.000329	0.000821	CcSEcCtD
Risperidone—Decreased appetite—Etoposide—muscle cancer	0.000329	0.00082	CcSEcCtD
Risperidone—Gastrointestinal disorder—Etoposide—muscle cancer	0.000327	0.000814	CcSEcCtD
Risperidone—Fatigue—Etoposide—muscle cancer	0.000326	0.000813	CcSEcCtD
Risperidone—Constipation—Etoposide—muscle cancer	0.000323	0.000806	CcSEcCtD
Risperidone—Pain—Etoposide—muscle cancer	0.000323	0.000806	CcSEcCtD
Risperidone—Dysuria—Doxorubicin—muscle cancer	0.000323	0.000804	CcSEcCtD
Risperidone—Neutropenia—Doxorubicin—muscle cancer	0.000323	0.000804	CcSEcCtD
Risperidone—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000321	0.000799	CcSEcCtD
Risperidone—Haemoglobin—Methotrexate—muscle cancer	0.00032	0.000799	CcSEcCtD
Risperidone—Diarrhoea—Vincristine—muscle cancer	0.000319	0.000796	CcSEcCtD
Risperidone—ABCB1—head—muscle cancer	0.000319	0.00427	CbGeAlD
Risperidone—Haemorrhage—Methotrexate—muscle cancer	0.000319	0.000795	CcSEcCtD
Risperidone—Hepatitis—Methotrexate—muscle cancer	0.000319	0.000795	CcSEcCtD
Risperidone—Pollakiuria—Doxorubicin—muscle cancer	0.000319	0.000794	CcSEcCtD
Risperidone—Pharyngitis—Methotrexate—muscle cancer	0.000316	0.000789	CcSEcCtD
Risperidone—Urinary tract disorder—Methotrexate—muscle cancer	0.000315	0.000785	CcSEcCtD
Risperidone—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000315	0.000785	CcSEcCtD
Risperidone—Weight increased—Doxorubicin—muscle cancer	0.000314	0.000783	CcSEcCtD
Risperidone—Urethral disorder—Methotrexate—muscle cancer	0.000313	0.000779	CcSEcCtD
Risperidone—Weight decreased—Doxorubicin—muscle cancer	0.000312	0.000778	CcSEcCtD
Risperidone—Feeling abnormal—Etoposide—muscle cancer	0.000312	0.000777	CcSEcCtD
Risperidone—Hyperglycaemia—Doxorubicin—muscle cancer	0.000311	0.000776	CcSEcCtD
Risperidone—Nausea—Dactinomycin—muscle cancer	0.00031	0.000774	CcSEcCtD
Risperidone—Pneumonia—Doxorubicin—muscle cancer	0.000309	0.000771	CcSEcCtD
Risperidone—Gastrointestinal pain—Etoposide—muscle cancer	0.000309	0.000771	CcSEcCtD
Risperidone—Dizziness—Vincristine—muscle cancer	0.000309	0.00077	CcSEcCtD
Risperidone—ABCB1—testis—muscle cancer	0.000308	0.00412	CbGeAlD
Risperidone—Infestation—Doxorubicin—muscle cancer	0.000308	0.000767	CcSEcCtD
Risperidone—Infestation NOS—Doxorubicin—muscle cancer	0.000308	0.000767	CcSEcCtD
Risperidone—Drowsiness—Doxorubicin—muscle cancer	0.000308	0.000767	CcSEcCtD
Risperidone—Visual impairment—Methotrexate—muscle cancer	0.000307	0.000766	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000305	0.00076	CcSEcCtD
Risperidone—Renal failure—Doxorubicin—muscle cancer	0.000302	0.000754	CcSEcCtD
Risperidone—Erythema multiforme—Methotrexate—muscle cancer	0.000301	0.000752	CcSEcCtD
Risperidone—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000301	0.000752	CcSEcCtD
Risperidone—Urticaria—Etoposide—muscle cancer	0.0003	0.000749	CcSEcCtD
Risperidone—Jaundice—Doxorubicin—muscle cancer	0.0003	0.000747	CcSEcCtD
Risperidone—Stomatitis—Doxorubicin—muscle cancer	0.0003	0.000747	CcSEcCtD
Risperidone—Body temperature increased—Etoposide—muscle cancer	0.000299	0.000745	CcSEcCtD
Risperidone—Abdominal pain—Etoposide—muscle cancer	0.000299	0.000745	CcSEcCtD
Risperidone—Conjunctivitis—Doxorubicin—muscle cancer	0.000299	0.000745	CcSEcCtD
Risperidone—Urinary tract infection—Doxorubicin—muscle cancer	0.000299	0.000745	CcSEcCtD
Risperidone—Eye disorder—Methotrexate—muscle cancer	0.000298	0.000743	CcSEcCtD
Risperidone—Tinnitus—Methotrexate—muscle cancer	0.000297	0.000741	CcSEcCtD
Risperidone—Vomiting—Vincristine—muscle cancer	0.000297	0.00074	CcSEcCtD
Risperidone—Cardiac disorder—Methotrexate—muscle cancer	0.000296	0.000738	CcSEcCtD
Risperidone—Sweating—Doxorubicin—muscle cancer	0.000295	0.000735	CcSEcCtD
Risperidone—Rash—Vincristine—muscle cancer	0.000294	0.000734	CcSEcCtD
Risperidone—Dermatitis—Vincristine—muscle cancer	0.000294	0.000733	CcSEcCtD
Risperidone—Haematuria—Doxorubicin—muscle cancer	0.000293	0.000731	CcSEcCtD
Risperidone—Headache—Vincristine—muscle cancer	0.000292	0.000729	CcSEcCtD
Risperidone—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000291	0.000725	CcSEcCtD
Risperidone—Epistaxis—Doxorubicin—muscle cancer	0.00029	0.000723	CcSEcCtD
Risperidone—Angiopathy—Methotrexate—muscle cancer	0.000289	0.000721	CcSEcCtD
Risperidone—Sinusitis—Doxorubicin—muscle cancer	0.000289	0.000719	CcSEcCtD
Risperidone—Immune system disorder—Methotrexate—muscle cancer	0.000288	0.000718	CcSEcCtD
Risperidone—Mediastinal disorder—Methotrexate—muscle cancer	0.000287	0.000716	CcSEcCtD
Risperidone—Agranulocytosis—Doxorubicin—muscle cancer	0.000287	0.000715	CcSEcCtD
Risperidone—Chills—Methotrexate—muscle cancer	0.000286	0.000713	CcSEcCtD
Risperidone—Alopecia—Methotrexate—muscle cancer	0.000282	0.000702	CcSEcCtD
Risperidone—Bradycardia—Doxorubicin—muscle cancer	0.000281	0.000701	CcSEcCtD
Risperidone—Mental disorder—Methotrexate—muscle cancer	0.000279	0.000696	CcSEcCtD
Risperidone—Hypersensitivity—Etoposide—muscle cancer	0.000279	0.000695	CcSEcCtD
Risperidone—Erythema—Methotrexate—muscle cancer	0.000278	0.000692	CcSEcCtD
Risperidone—Malnutrition—Methotrexate—muscle cancer	0.000278	0.000692	CcSEcCtD
Risperidone—Haemoglobin—Doxorubicin—muscle cancer	0.000277	0.000692	CcSEcCtD
Risperidone—Nausea—Vincristine—muscle cancer	0.000277	0.000691	CcSEcCtD
Risperidone—Rhinitis—Doxorubicin—muscle cancer	0.000277	0.00069	CcSEcCtD
Risperidone—Haemorrhage—Doxorubicin—muscle cancer	0.000276	0.000688	CcSEcCtD
Risperidone—Hepatitis—Doxorubicin—muscle cancer	0.000276	0.000688	CcSEcCtD
Risperidone—Hypoaesthesia—Doxorubicin—muscle cancer	0.000275	0.000685	CcSEcCtD
Risperidone—Pharyngitis—Doxorubicin—muscle cancer	0.000274	0.000683	CcSEcCtD
Risperidone—Urinary tract disorder—Doxorubicin—muscle cancer	0.000273	0.00068	CcSEcCtD
Risperidone—Oedema peripheral—Doxorubicin—muscle cancer	0.000272	0.000678	CcSEcCtD
Risperidone—Dysgeusia—Methotrexate—muscle cancer	0.000272	0.000678	CcSEcCtD
Risperidone—Asthenia—Etoposide—muscle cancer	0.000271	0.000676	CcSEcCtD
Risperidone—Connective tissue disorder—Doxorubicin—muscle cancer	0.000271	0.000676	CcSEcCtD
Risperidone—Urethral disorder—Doxorubicin—muscle cancer	0.000271	0.000675	CcSEcCtD
Risperidone—Back pain—Methotrexate—muscle cancer	0.000268	0.000669	CcSEcCtD
Risperidone—Pruritus—Etoposide—muscle cancer	0.000268	0.000667	CcSEcCtD
Risperidone—Visual impairment—Doxorubicin—muscle cancer	0.000266	0.000663	CcSEcCtD
Risperidone—Vision blurred—Methotrexate—muscle cancer	0.000262	0.000652	CcSEcCtD
Risperidone—Erythema multiforme—Doxorubicin—muscle cancer	0.000261	0.000651	CcSEcCtD
Risperidone—Diarrhoea—Etoposide—muscle cancer	0.000259	0.000645	CcSEcCtD
Risperidone—Eye disorder—Doxorubicin—muscle cancer	0.000258	0.000643	CcSEcCtD
Risperidone—Ill-defined disorder—Methotrexate—muscle cancer	0.000258	0.000642	CcSEcCtD
Risperidone—Tinnitus—Doxorubicin—muscle cancer	0.000257	0.000642	CcSEcCtD
Risperidone—Anaemia—Methotrexate—muscle cancer	0.000257	0.00064	CcSEcCtD
Risperidone—Cardiac disorder—Doxorubicin—muscle cancer	0.000256	0.000639	CcSEcCtD
Risperidone—Flushing—Doxorubicin—muscle cancer	0.000256	0.000639	CcSEcCtD
Risperidone—Angiopathy—Doxorubicin—muscle cancer	0.00025	0.000624	CcSEcCtD
Risperidone—Malaise—Methotrexate—muscle cancer	0.00025	0.000624	CcSEcCtD
Risperidone—Dizziness—Etoposide—muscle cancer	0.00025	0.000623	CcSEcCtD
Risperidone—Immune system disorder—Doxorubicin—muscle cancer	0.000249	0.000622	CcSEcCtD
Risperidone—Vertigo—Methotrexate—muscle cancer	0.000249	0.000622	CcSEcCtD
Risperidone—Mediastinal disorder—Doxorubicin—muscle cancer	0.000249	0.00062	CcSEcCtD
Risperidone—Leukopenia—Methotrexate—muscle cancer	0.000248	0.000619	CcSEcCtD
Risperidone—Chills—Doxorubicin—muscle cancer	0.000248	0.000618	CcSEcCtD
Risperidone—Arrhythmia—Doxorubicin—muscle cancer	0.000247	0.000615	CcSEcCtD
Risperidone—Alopecia—Doxorubicin—muscle cancer	0.000244	0.000608	CcSEcCtD
Risperidone—Cough—Methotrexate—muscle cancer	0.000242	0.000604	CcSEcCtD
Risperidone—Mental disorder—Doxorubicin—muscle cancer	0.000242	0.000603	CcSEcCtD
Risperidone—Convulsion—Methotrexate—muscle cancer	0.00024	0.0006	CcSEcCtD
Risperidone—Vomiting—Etoposide—muscle cancer	0.00024	0.000599	CcSEcCtD
Risperidone—Erythema—Doxorubicin—muscle cancer	0.00024	0.000599	CcSEcCtD
Risperidone—Malnutrition—Doxorubicin—muscle cancer	0.00024	0.000599	CcSEcCtD
Risperidone—Rash—Etoposide—muscle cancer	0.000238	0.000594	CcSEcCtD
Risperidone—Dermatitis—Etoposide—muscle cancer	0.000238	0.000594	CcSEcCtD
Risperidone—Headache—Etoposide—muscle cancer	0.000237	0.000591	CcSEcCtD
Risperidone—Flatulence—Doxorubicin—muscle cancer	0.000237	0.00059	CcSEcCtD
Risperidone—Chest pain—Methotrexate—muscle cancer	0.000236	0.000589	CcSEcCtD
Risperidone—Arthralgia—Methotrexate—muscle cancer	0.000236	0.000589	CcSEcCtD
Risperidone—Myalgia—Methotrexate—muscle cancer	0.000236	0.000589	CcSEcCtD
Risperidone—Tension—Doxorubicin—muscle cancer	0.000236	0.000588	CcSEcCtD
Risperidone—Dysgeusia—Doxorubicin—muscle cancer	0.000235	0.000587	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000235	0.000585	CcSEcCtD
Risperidone—Discomfort—Methotrexate—muscle cancer	0.000233	0.000582	CcSEcCtD
Risperidone—Nervousness—Doxorubicin—muscle cancer	0.000233	0.000582	CcSEcCtD
Risperidone—Back pain—Doxorubicin—muscle cancer	0.000232	0.00058	CcSEcCtD
Risperidone—Muscle spasms—Doxorubicin—muscle cancer	0.000231	0.000576	CcSEcCtD
Risperidone—Confusional state—Methotrexate—muscle cancer	0.000228	0.000569	CcSEcCtD
Risperidone—Anaphylactic shock—Methotrexate—muscle cancer	0.000227	0.000565	CcSEcCtD
Risperidone—Vision blurred—Doxorubicin—muscle cancer	0.000227	0.000565	CcSEcCtD
Risperidone—Infection—Methotrexate—muscle cancer	0.000225	0.000561	CcSEcCtD
Risperidone—Nausea—Etoposide—muscle cancer	0.000225	0.00056	CcSEcCtD
Risperidone—Ill-defined disorder—Doxorubicin—muscle cancer	0.000223	0.000556	CcSEcCtD
Risperidone—Nervous system disorder—Methotrexate—muscle cancer	0.000222	0.000554	CcSEcCtD
Risperidone—Anaemia—Doxorubicin—muscle cancer	0.000222	0.000554	CcSEcCtD
Risperidone—Thrombocytopenia—Methotrexate—muscle cancer	0.000222	0.000553	CcSEcCtD
Risperidone—Agitation—Doxorubicin—muscle cancer	0.000221	0.000551	CcSEcCtD
Risperidone—Skin disorder—Methotrexate—muscle cancer	0.00022	0.000549	CcSEcCtD
Risperidone—Hyperhidrosis—Methotrexate—muscle cancer	0.000219	0.000546	CcSEcCtD
Risperidone—Malaise—Doxorubicin—muscle cancer	0.000217	0.00054	CcSEcCtD
Risperidone—Vertigo—Doxorubicin—muscle cancer	0.000216	0.000538	CcSEcCtD
Risperidone—Anorexia—Methotrexate—muscle cancer	0.000216	0.000538	CcSEcCtD
Risperidone—Syncope—Doxorubicin—muscle cancer	0.000216	0.000537	CcSEcCtD
Risperidone—Leukopenia—Doxorubicin—muscle cancer	0.000215	0.000536	CcSEcCtD
Risperidone—Palpitations—Doxorubicin—muscle cancer	0.000212	0.000529	CcSEcCtD
Risperidone—Hypotension—Methotrexate—muscle cancer	0.000212	0.000528	CcSEcCtD
Risperidone—Loss of consciousness—Doxorubicin—muscle cancer	0.000211	0.000527	CcSEcCtD
Risperidone—Cough—Doxorubicin—muscle cancer	0.00021	0.000523	CcSEcCtD
Risperidone—Convulsion—Doxorubicin—muscle cancer	0.000208	0.000519	CcSEcCtD
Risperidone—Hypertension—Doxorubicin—muscle cancer	0.000208	0.000517	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000206	0.000514	CcSEcCtD
Risperidone—Insomnia—Methotrexate—muscle cancer	0.000205	0.000511	CcSEcCtD
Risperidone—Myalgia—Doxorubicin—muscle cancer	0.000205	0.00051	CcSEcCtD
Risperidone—Arthralgia—Doxorubicin—muscle cancer	0.000205	0.00051	CcSEcCtD
Risperidone—Chest pain—Doxorubicin—muscle cancer	0.000205	0.00051	CcSEcCtD
Risperidone—Anxiety—Doxorubicin—muscle cancer	0.000204	0.000508	CcSEcCtD
Risperidone—Paraesthesia—Methotrexate—muscle cancer	0.000203	0.000507	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000203	0.000507	CcSEcCtD
Risperidone—Discomfort—Doxorubicin—muscle cancer	0.000202	0.000504	CcSEcCtD
Risperidone—Dyspnoea—Methotrexate—muscle cancer	0.000202	0.000503	CcSEcCtD
Risperidone—Somnolence—Methotrexate—muscle cancer	0.000201	0.000502	CcSEcCtD
Risperidone—Dry mouth—Doxorubicin—muscle cancer	0.0002	0.000499	CcSEcCtD
Risperidone—Dyspepsia—Methotrexate—muscle cancer	0.000199	0.000497	CcSEcCtD
Risperidone—Confusional state—Doxorubicin—muscle cancer	0.000198	0.000493	CcSEcCtD
Risperidone—Decreased appetite—Methotrexate—muscle cancer	0.000197	0.000491	CcSEcCtD
Risperidone—Anaphylactic shock—Doxorubicin—muscle cancer	0.000196	0.000489	CcSEcCtD
Risperidone—Oedema—Doxorubicin—muscle cancer	0.000196	0.000489	CcSEcCtD
Risperidone—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000196	0.000488	CcSEcCtD
Risperidone—Fatigue—Methotrexate—muscle cancer	0.000195	0.000487	CcSEcCtD
Risperidone—Infection—Doxorubicin—muscle cancer	0.000195	0.000486	CcSEcCtD
Risperidone—Pain—Methotrexate—muscle cancer	0.000194	0.000483	CcSEcCtD
Risperidone—Shock—Doxorubicin—muscle cancer	0.000193	0.000481	CcSEcCtD
Risperidone—Nervous system disorder—Doxorubicin—muscle cancer	0.000192	0.00048	CcSEcCtD
Risperidone—Thrombocytopenia—Doxorubicin—muscle cancer	0.000192	0.000479	CcSEcCtD
Risperidone—Tachycardia—Doxorubicin—muscle cancer	0.000191	0.000477	CcSEcCtD
Risperidone—Skin disorder—Doxorubicin—muscle cancer	0.000191	0.000475	CcSEcCtD
Risperidone—Hyperhidrosis—Doxorubicin—muscle cancer	0.00019	0.000473	CcSEcCtD
Risperidone—Anorexia—Doxorubicin—muscle cancer	0.000187	0.000466	CcSEcCtD
Risperidone—Feeling abnormal—Methotrexate—muscle cancer	0.000187	0.000465	CcSEcCtD
Risperidone—Gastrointestinal pain—Methotrexate—muscle cancer	0.000185	0.000462	CcSEcCtD
Risperidone—Hypotension—Doxorubicin—muscle cancer	0.000183	0.000457	CcSEcCtD
Risperidone—Urticaria—Methotrexate—muscle cancer	0.00018	0.000449	CcSEcCtD
Risperidone—Abdominal pain—Methotrexate—muscle cancer	0.000179	0.000446	CcSEcCtD
Risperidone—Body temperature increased—Methotrexate—muscle cancer	0.000179	0.000446	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000179	0.000446	CcSEcCtD
Risperidone—Insomnia—Doxorubicin—muscle cancer	0.000177	0.000442	CcSEcCtD
Risperidone—Paraesthesia—Doxorubicin—muscle cancer	0.000176	0.000439	CcSEcCtD
Risperidone—Dyspnoea—Doxorubicin—muscle cancer	0.000175	0.000436	CcSEcCtD
Risperidone—Somnolence—Doxorubicin—muscle cancer	0.000174	0.000435	CcSEcCtD
Risperidone—Dyspepsia—Doxorubicin—muscle cancer	0.000173	0.00043	CcSEcCtD
Risperidone—Decreased appetite—Doxorubicin—muscle cancer	0.000171	0.000425	CcSEcCtD
Risperidone—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000169	0.000422	CcSEcCtD
Risperidone—Fatigue—Doxorubicin—muscle cancer	0.000169	0.000422	CcSEcCtD
Risperidone—Pain—Doxorubicin—muscle cancer	0.000168	0.000418	CcSEcCtD
Risperidone—Constipation—Doxorubicin—muscle cancer	0.000168	0.000418	CcSEcCtD
Risperidone—Hypersensitivity—Methotrexate—muscle cancer	0.000167	0.000416	CcSEcCtD
Risperidone—Asthenia—Methotrexate—muscle cancer	0.000163	0.000405	CcSEcCtD
Risperidone—Feeling abnormal—Doxorubicin—muscle cancer	0.000162	0.000403	CcSEcCtD
Risperidone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00016	0.0004	CcSEcCtD
Risperidone—Pruritus—Methotrexate—muscle cancer	0.00016	0.0004	CcSEcCtD
Risperidone—Urticaria—Doxorubicin—muscle cancer	0.000156	0.000388	CcSEcCtD
Risperidone—Abdominal pain—Doxorubicin—muscle cancer	0.000155	0.000387	CcSEcCtD
Risperidone—Body temperature increased—Doxorubicin—muscle cancer	0.000155	0.000387	CcSEcCtD
Risperidone—Diarrhoea—Methotrexate—muscle cancer	0.000155	0.000386	CcSEcCtD
Risperidone—Dizziness—Methotrexate—muscle cancer	0.00015	0.000373	CcSEcCtD
Risperidone—Hypersensitivity—Doxorubicin—muscle cancer	0.000145	0.00036	CcSEcCtD
Risperidone—Vomiting—Methotrexate—muscle cancer	0.000144	0.000359	CcSEcCtD
Risperidone—Rash—Methotrexate—muscle cancer	0.000143	0.000356	CcSEcCtD
Risperidone—Dermatitis—Methotrexate—muscle cancer	0.000143	0.000356	CcSEcCtD
Risperidone—Headache—Methotrexate—muscle cancer	0.000142	0.000354	CcSEcCtD
Risperidone—Asthenia—Doxorubicin—muscle cancer	0.000141	0.000351	CcSEcCtD
Risperidone—Pruritus—Doxorubicin—muscle cancer	0.000139	0.000346	CcSEcCtD
Risperidone—Nausea—Methotrexate—muscle cancer	0.000135	0.000335	CcSEcCtD
Risperidone—Diarrhoea—Doxorubicin—muscle cancer	0.000134	0.000335	CcSEcCtD
Risperidone—Dizziness—Doxorubicin—muscle cancer	0.00013	0.000323	CcSEcCtD
Risperidone—Vomiting—Doxorubicin—muscle cancer	0.000125	0.000311	CcSEcCtD
Risperidone—Rash—Doxorubicin—muscle cancer	0.000124	0.000308	CcSEcCtD
Risperidone—Dermatitis—Doxorubicin—muscle cancer	0.000124	0.000308	CcSEcCtD
Risperidone—Headache—Doxorubicin—muscle cancer	0.000123	0.000306	CcSEcCtD
Risperidone—Nausea—Doxorubicin—muscle cancer	0.000117	0.00029	CcSEcCtD
